Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Artrya Limited ( (AU:AYA) ) is now available.
Artrya Limited has announced the quotation of 100,000 ordinary fully paid securities on the Australian Securities Exchange (ASX), effective July 28, 2025. This move is part of the company’s strategy to enhance its market presence and provide more liquidity for its stakeholders, potentially strengthening its position in the healthcare sector.
The most recent analyst rating on (AU:AYA) stock is a Buy with a A$2.21 price target. To see the full list of analyst forecasts on Artrya Limited stock, see the AU:AYA Stock Forecast page.
More about Artrya Limited
Artrya Limited operates in the healthcare industry, focusing on developing and providing advanced medical imaging solutions. The company is known for its innovative technologies that aid in the diagnosis and management of cardiovascular diseases.
Average Trading Volume: 217,037
Technical Sentiment Signal: Buy
Find detailed analytics on AYA stock on TipRanks’ Stock Analysis page.